Cellyan Biotechnology Co Ltd (HKPD)
Cellyan Biotechnology Co., Ltd. is a Hong Kong-based company incorporated in 2023 and listed on NASDAQ as common stock under the ticker HKPD. The company operates as an investment holding company with activities centered on the over-the-counter pharmaceutical sector in Hong Kong and Mainland China. Its business includes cross-border procurement and distribution of OTC pharmaceuticals, along with e-commerce supply chain services. The company also provides related logistics support such as customs clearance, drug registration services, warehousing, and other supply chain functions. Cellyan Biotechnology serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was previously known as Hong Kong Pharma Digital Technology Holdings Limited and adopted its current name in December 2025. It is based in Yau Tong, Hong Kong.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-HKPD
|
$0.45
|
21.9% Upside
|
Undervalued
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 14, 2026
|
-13.1x
|
1.8x
|
0.6x
|
8.347 M
|
8.956 M
|
21.2%
|
66.9%
|
8.6
|
—
|
70.1%
|
